Cotoi TC

No ORCID on file · 3 papers in corpus · active 2022-2024

Study types

  • review 2

Condition tags

  • endometriosis 2
  • adenomyosis 1
review 2024
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph17030311

Endometriosis and adenomyosis behave similarly to cancer. No current treatments represent a cure, even if there are several options, including hormonal and surgical therapy. In advanced or recurrent pathologies, however, personalized treatm…

review 2023
Diagnostics ·doi:10.3390/diagnostics13132265

This comprehensive review explores the genetic contributions to endometriosis and their potential impact on improving diagnostic techniques. The review begins by defining endometriosis and discussing its prevalence, emphasizing the need for…

2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12123105

Dysgerminoma represents a rare malignant tumor composed of germ cells, originally from the embryonic gonads. Regarding its incidence, we do not have precise data due to its rarity. Dysgerminoma occurs at a fertile age. The preferred treatme…